Dear SaaStr:  I Have Some Shares in a Successful Start-Up I Worked At, But the Company Won’t Let Me Sell Them.  Why Not?? It’s a...

NYCB’s Tale: $552M Loss & Real Estate Shifts The story of New York Community Bank (NYCB) is a tale of banking milestones and financial fluctuations,...

Need a score? Well, you’re a winner now that you’ve found my Blue Lock Blaze Battle Tier List. My tier ranks each player from...

However, the report pointed out that timing the altcoin season is a "risky sport," as the bitcoin ETFs have altered the crypto investment landscape,...

Even if you don't suffer from range anxiety, knowing how far your electric car can travel on a charge is obviously incredibly important. Maybe...

Eight US states passed data privacy legislation in 2023, and in 2024, laws will come into effect in four, including Oregon, Montana, and Texas,...

Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies?...

Although most startup chipmakers have not seen much love from investors so far this year, Recogni seems to have bucked that trend. The San Jose,...

There is another migrant crisis brewing. Unlike the one at the southern border, this one will be all over the country.A recent Harvard study...

The resilience of the U.S. economy has been a surprise to Wall Street, and the Federal Reserve, for well over a year now, and...

NEW FILINGS Company: Kyverna Therapeutcs, Inc. Symbol: KYTX (Nasdaq) Description: They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune...